ianalumab development code monoclonal antibody investigated autoimmune hepatitis multiple sclerosis pemphigus vulgaris rheumatoid arthritis sj√∂gren syndrome systemic lupus drug developed novartis ianalumab undergoing phase iiiii june ianalumab involved clinical trials completed ongoing planned immune activation dostarlimab ibalizumab monoclonal article stub help wikipedia expanding httpsenwikipediaorgwikiianalumab